12:00 AM
 | 
Aug 13, 2012
 |  BC Week In Review  |  Company News  |  Other News

Gliacor Therapeutics, PsychoGenics, The Michael J. Fox Foundation for Parkinson's Research neurology news

The foundation named PsychoGenics and Gliacor as the 3Q12 participants in its Partnering Program. The program presents participants' projects to potential investors....

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >